Table 1

 Summary of patient demographic data, BAL and pathological rejection assessments

Subject noAgeDiagnosisMonths after transplantBAL return (ml)Cell count (×104/ml)PMN(%)AM(%)Lymph(%)MicrobiologyBiopsyPPI/H2Pepsin(ng/ml)
CF, cystic fibrosis; PPH, primary pulmonary hypertension; OB, obliterative bronchiolitis (patient had a second lung transplant due to failure of the first); A1AT, α1-antitrypsin deficiency; LAM, lymphangiomyomatosis; VSD-EISEN, Eisenmenger’s syndrome; PMN, neutrophils; AM, alveolar macrophages; Lymph, lymphocytes; Biopsy, pathological assessment for rejection according to International Society for Heart and Lung Transplantation criteria: a = acute rejection ⩽a1 non-significant, b = airway assessment, axbx = no material for assessment; PPI/H2, prophylactic treatment with proton pump inhibitor or H2 receptor antagonist.
119CF370360.299.60.2Negativea2/b1Yes81
245Bronchiectasis69567.20.296.43.4Negativea0/b1Yes60
325PPH2.510024.31.098.80.2Negativea2/3b1Yes172
425OB310034.33.496.20.2Negativea1/bxYes68
520CF0.255556.535.661.03.0Negativea2/bxNo129
641A1AT2.58522.87.486.45.0Negativea2/b0No50
744LAM6100111.094.64.4Negativea1/b1Yes34
844VSD-EISEN87952.61.493.05.6 Aspergillus a0/b0Yes67
938CF6804.74.675.818.4 Klebsiella a1/b1Yes107
1062LAM129039.92.094.43.6Negativea0/bxNo1375
1139Bronchiectasis3759.68.076.015.8Negativea0/b0Yes225
1247A1AT27522.65.694.20.2Negativea2/b0Yes1200
1321CF12958.51.098.20.6 Penicillium a0/b0Yes237